BriaCell Therapeutics Corp.

Toronto Stock Exchange BCT.TO

BriaCell Therapeutics Corp. Market Capitalization on February 05, 2025: USD 13.34 M

BriaCell Therapeutics Corp. Market Capitalization is USD 13.34 M on February 05, 2025, a -89.29% change year over year. Market capitalization represents total company value in stock market; higher suggests larger, more established company.
  • BriaCell Therapeutics Corp. 52-week high Market Capitalization is USD 132.12 M on February 06, 2024, which is 890.08% above the current Market Capitalization.
  • BriaCell Therapeutics Corp. 52-week low Market Capitalization is USD 1.11 M on January 20, 2025, which is -91.67% below the current Market Capitalization.
  • BriaCell Therapeutics Corp. average Market Capitalization for the last 52 weeks is USD 47.54 M.
Key data
Date Market Capitalization Share Price Price to Earnings Ratio (P/E) Price to Sales Ratio (P/S)
Market news
Loading...
SV Wall Street
Toronto Stock Exchange: BCT.TO

BriaCell Therapeutics Corp.

CEO Dr. William V. Williams M.D.
IPO Date Aug. 13, 2012
Location Canada
Headquarters Bellevue Centre
Employees 16
Sector Healthcare
Industries
Description

BriaCell Therapeutics Corp., an immuno-oncology-focused biotechnology company, engages in developing immunotherapies for the management of cancer. Its lead drug candidate is Bria-IMT, a whole-cell cancer vaccine that is in Phase I/IIa clinical trials in combination with the immunotherapy development candidates retifanlimab. The company is also developing Bria-OTS, an off-the-shelf personalized immunotherapy for advanced breast cancer; and BriaDx, a diagnostic test that determines the patients' HLA types. It has a non-exclusive clinical trial collaboration with Incyte Corporation to evaluate the effects of combinations of novel clinical candidates; and a cooperative research and development agreement with the National Cancer Institute to conduct preclinical studies to develop and test Bria-OTS cellular immunotherapy as a treatment for cancer. BriaCell Therapeutics Corp. is based in West Vancouver, Canada.

Similar companies

MDNA.TO

Medicenna Therapeutics Corp.

USD 0.85

-3.04%

EPRX.TO

Eupraxia Pharmaceuticals Inc.

USD 3.07

-0.98%

HLS.TO

HLS Therapeutics Inc.

USD 2.96

1.10%

StockViz Staff

February 6, 2025

Any question? Send us an email